Today: 7 February 2026
Subscribe
Browse Category

Investment Insights News 15 December 2025 - 16 December 2025

SoFi Technologies Stock After Hours (Dec. 15, 2025): Why SOFI Dropped, Fresh Headlines, Analyst Forecasts, and What to Watch Before Tuesday’s Open

SoFi Technologies Stock After Hours (Dec. 15, 2025): Why SOFI Dropped, Fresh Headlines, Analyst Forecasts, and What to Watch Before Tuesday’s Open

SoFi Technologies, Inc. (NASDAQ: SOFI) ended Monday, December 15, 2025, sharply lower, and the stock stayed active in extended trading after the closing bell. SOFI finished the regular session around $25.81–$25.82 (down about 5.35%–5.4%) and traded around $25.71 in late afternoon after-hours quotes. ChartExchange+2Investing.com+2 The pullback matters because SoFi has been one of 2025’s most-watched fintech momentum names—meaning any combination of dilution concerns, valuation debates, and macro-rate headlines can hit sentiment quickly. Below is what investors and traders should know tonight (after the bell on Dec. 15) before the U.S. market opens Tuesday, Dec. 16, 2025. SOFI stock after the
16 December 2025
····
Salesforce (CRM) Stock After Hours Today (Dec. 15, 2025): Why Shares Fell, What’s Moving the AI Thesis, and What to Watch Before Tuesday’s Open

Salesforce (CRM) Stock After Hours Today (Dec. 15, 2025): Why Shares Fell, What’s Moving the AI Thesis, and What to Watch Before Tuesday’s Open

Salesforce, Inc. (NYSE: CRM) ended Monday’s session under pressure and stayed soft in extended trading. CRM closed at $254.58, down 2.92%, and was $253.50 in after-hours trading as of 5:59 p.m. ET (down another 0.42% from the close). StockAnalysis That “after the bell” drift doesn’t point to a single new catalyst hitting the tape late in the day. Instead, Salesforce is being pulled by a familiar mix: risk-off sentiment in AI and mega-cap tech, heavy macro data risk into Tuesday morning, and ongoing investor debate over how quickly Salesforce can monetize Agentforce at scale. Below is what happened today—and what
16 December 2025
····
Circle Internet Group, Inc. (CRCL) Stock Today: Latest News, Price Move, and Wall Street Forecasts (Dec. 15, 2025)

Circle Internet Group, Inc. (CRCL) Stock Today: Latest News, Price Move, and Wall Street Forecasts (Dec. 15, 2025)

Circle Internet Group, Inc. (NYSE: CRCL) is back in the spotlight on December 15, 2025, as investors weigh a fresh technology push, an expanding regulatory footprint, and intensifying debate over how stablecoin issuers should be supervised inside the U.S. financial system. By mid‑session Monday, CRCL shares were down about 9% near $76, after trading in a wide intraday range. That drop landed even as Circle announced an agreement tied to cross‑chain infrastructure and as legal and policy scrutiny continued to build around federal trust bank charters for crypto firms. Below is a detailed, news‑driven look at what moved Circle stock
15 December 2025
···
Coherent Corp. (COHR) Stock: JPMorgan Raises Target to $215 as AI Data-Center Catalysts Drive Fresh Focus (Dec. 15, 2025)

Coherent Corp. (COHR) Stock: JPMorgan Raises Target to $215 as AI Data-Center Catalysts Drive Fresh Focus (Dec. 15, 2025)

As of Monday, December 15, 2025, Coherent Corp. (NYSE: COHR) is back in the spotlight after a new wave of analyst commentary and product momentum rekindled investor interest in the photonics and advanced materials name. The stock traded around $180 in the latest session, with an intraday range roughly spanning the mid-$170s to low-$180s, as traders weighed upbeat growth narratives against ongoing volatility in AI-linked equities. What’s powering the renewed attention is a clear convergence of themes that matter to the market right now: AI data-center buildouts, next-generation optical networking (including “multi-rail” infrastructure), and silicon carbide (SiC) materials that address
15 December 2025
····
CECO Environmental Corp Stock News Today (NASDAQ: CECO): Record $135M Order, $1B Bookings Outlook, and What Analysts Forecast Next

CECO Environmental Corp Stock News Today (NASDAQ: CECO): Record $135M Order, $1B Bookings Outlook, and What Analysts Forecast Next

CECO Environmental Corp. (Nasdaq: CECO) is in the spotlight on December 15, 2025, after the company announced its largest order ever—exceeding $135 million—for an emissions management solution tied to a Texas-based natural gas power generation facility supporting data center expansion. The headline matters not just because it’s big, but because management says it helps push full‑year 2025 bookings above $1 billion, with backlog approaching or exceeding $800 million. GlobeNewswire+1 In market trading on Dec. 15, CECO shares hovered around the low $60s and touched an intraday high in the mid‑$63 range on some quote feeds, keeping the stock near recent
15 December 2025
····
Corebridge Financial (CRBG) Stock Jumps Ahead of S&P MidCap 400 Addition: Latest News, Dividend, and Analyst Forecasts (Dec. 15, 2025)

Corebridge Financial (CRBG) Stock Jumps Ahead of S&P MidCap 400 Addition: Latest News, Dividend, and Analyst Forecasts (Dec. 15, 2025)

Corebridge Financial, Inc. (NYSE: CRBG) is getting a very specific kind of attention on December 15, 2025: the “index inclusion + dividend setup” cocktail that tends to light up screens, drive short-term flows, and trigger a lot of fast-twitch trading. By late morning in U.S. trading hours, CRBG was around $32.21, up about 2.1% on the day, after touching an intraday high near $32.87. Trading volume was already above 5 million shares, with the company’s market capitalization hovering around $16.4 billion. The immediate catalyst is straightforward: Corebridge is scheduled to join the S&P MidCap 400 on Wednesday, Dec. 17, and
15 December 2025
···
Immunome (IMNM) Stock Surges After Positive Phase 3 Varegacestat Data: Latest News, Analyst Forecasts, and What Comes Next (Dec. 15, 2025)

Immunome (IMNM) Stock Surges After Positive Phase 3 Varegacestat Data: Latest News, Analyst Forecasts, and What Comes Next (Dec. 15, 2025)

December 15, 2025 — Immunome, Inc. (NASDAQ: IMNM) is having the kind of biotech day that traders circle in red ink: a major clinical trial win, a sharp move in the share price, and a fast-rising debate over what “best-in-class” might be worth if regulators agree. The catalyst is Immunome’s positive topline Phase 3 RINGSIDE results for varegacestat (formerly AL102) in progressing desmoid tumors—a rare, non-metastatic but often aggressive disease that can cause severe pain and disability. Reuters reported the news pushed the stock up 34.3% in premarket trading Monday. Reuters By mid-session, IMNM remained strongly higher. As of 14:46
15 December 2025
·····
Ford Motor Company Stock (NYSE: F) News Today: Key Headlines, Analyst Forecasts, and What’s Driving Ford Shares on Dec. 15, 2025

Ford Motor Company Stock (NYSE: F) News Today: Key Headlines, Analyst Forecasts, and What’s Driving Ford Shares on Dec. 15, 2025

Ford Motor Company stock (NYSE: F) is starting the week in focus as investors weigh a fresh batch of policy signals, EV demand crosscurrents, and a growing list of “pragmatic” strategic moves—especially in Europe. In early indications on Monday, Dec. 15, Ford shares traded around the mid-$13 range, after finishing last week near $13.6. StockAnalysis This isn’t one of those sleepy “legacy auto” tape stories right now. The market’s question is sharper: can Ford keep harvesting strong cash generation from trucks and commercial vehicles while retooling its EV strategy—without getting crushed by regulatory whiplash, China-linked supply chain constraints, or the
15 December 2025
····
Gold Price in Germany Today: Spot Near €3,695/oz as Dollar Softens — Latest News, Drivers and 2026 Forecasts (15 Dec 2025)

Gold Price in Germany Today: Spot Near €3,695/oz as Dollar Softens — Latest News, Drivers and 2026 Forecasts (15 Dec 2025)

Gold prices in Germany climbed on Monday, December 15, as global bullion demand firmed and the euro-denominated spot price edged closer to recent records. By today’s quoted levels, gold in euros is trading around €3,694 per troy ounce (Feinunze) — a move that keeps the precious metal in striking distance of its all-time highs set earlier this year. GOLD.DE At the same time, international markets are watching a packed macro calendar and shifting interest-rate expectations, both of which continue to dominate day-to-day moves in gold. Gold price in Germany today (EUR): latest spot levels Gold is typically priced globally in
15 December 2025
···
Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica Inc. (NYSE: CLS; TSX: CLS) is back in the spotlight on December 15, 2025 after a sharp pullback that reminded investors of an uncomfortable truth: even “AI infrastructure winners” can get whipsawed when the market mood flips. On the NYSE, Celestica closed at $306.50 on December 12, down $44.91 (-12.78%), and was indicated higher in early pre-market trading on December 15 around $312.10 (+1.83%). StockAnalysis So what’s driving the move, what’s new in today’s news flow, and what do forecasts look like heading into 2026? Why Celestica stock dropped: the selloff was bigger than one company The most important
15 December 2025
······
Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) entered a new phase in its corporate life this month: from clinical-stage story stock to a company with an FDA-approved, commercially launchable cardiovascular product. The catalyst is CARDAMYST™ (etripamil) nasal spray, now approved in the U.S. for adults experiencing acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT)—a rapid heart rhythm disturbance that can be frightening, disruptive, and costly when it sends patients to emergency care. GlobeNewswire Yet in classic biotech fashion, the stock market’s reaction has been anything but simple. Despite the “yes” from regulators, MIST shares saw sharp volatility into the weekend, and investors
15 December 2025
·····
Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth Corporation stock is back in the spotlight on December 15, 2025, as the cannabis sector reacts to a fresh wave of reporting that President Donald Trump may soon move to ease federal marijuana restrictions—specifically by reclassifying cannabis as a Schedule III drug under U.S. law. In early European trading on Monday, Canopy Growth led the group, jumping as much as 17.9% and extending a dramatic rally from the prior session. Reuters For investors, traders, and anyone trying to separate “real policy catalyst” from “market caffeine,” the key story today is simple: CGC is moving hard because U.S. federal
15 December 2025
····
1 … 35 36 37 38 39 … 66

Stock Market Today

Northern Star Resources share price dips into weekend as $50m Central Tanami deal closes

Northern Star Resources share price dips into weekend as $50m Central Tanami deal closes

7 February 2026
Northern Star Resources fell 1.7% to A$26.77 Friday, extending losses as gold miners and the broader market declined. MGX Resources completed its A$50 million purchase of a 50% stake in the Central Tanami Gold Project from Northern Star. The All Ordinaries Gold index dropped 3.24%. CME Group raised COMEX gold futures margin requirements to 9% amid volatility.
PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

7 February 2026
PLS Group shares closed at A$4.12 Friday, down 1.2% after a 3.7% drop Thursday. Morgan Stanley and Mitsubishi UFJ Financial Group disclosed increased voting power in the lithium miner, both citing changes dated Feb. 2. The moves came as lithium prices fell and Australian equities posted their sharpest drop in months. PLS reports interim results Feb. 19.
Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

7 February 2026
Commonwealth Bank of Australia shares closed at A$158.91, down 0.23% Friday, as the S&P/ASX 200 fell 2.03% and nearly A$70 billion was wiped from the market. The bank reports half-year results and an interim dividend on Feb. 11, with shares going ex-dividend Feb. 18. CBA flagged a A$68 million provision linked to ASIC’s Better Banking review. The RBA raised rates to 3.85% on Feb. 3, with CBA passing on the increase from Feb. 13.
Go toTop